Literature DB >> 6368298

Cell-mediated cytotoxic islet cell surface antibodies to human pancreatic beta cells.

T Maruyama, I Takei, I Matsuba, A Tsuruoka, M Taniyama, Y Ikeda, K Kataoka, M Abe, S Matsuki.   

Abstract

Sera containing islet cell surface antibodies show a complement-dependent cytotoxic reaction against islet cells, but it has not yet been clarified whether islet cell surface antibodies exhibit cell-mediated cytotoxicity to these cells. By 51Cr release assay we investigated whether islet cell surface antibodies showed a cytotoxic reaction to human pancreatic B cells (JHPI-1 clone) in the presence of normal human lymphocytes. The sera from 14 islet cell surface antibody-positive, 16 islet cell surface antibody-negative Type 1 (insulin-dependent) diabetic patients and 18 islet cell surface antibody-negative healthy subjects were studied. Four sera containing islet cell surface antibodies showed specific cytotoxicity above the mean +3SD value of healthy subjects, and the mean specific cytotoxicity of islet cell surface antibody-positive sera differed significantly from that of both islet cell surface antibody-negative groups. These results suggest that this cell-mediated cytotoxic mechanism may play an important role in the pathogenesis of Type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368298     DOI: 10.1007/bf00252259

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

2.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

3.  Effect of specific antibody to target cells on their specific and non-specific interactions with lymphocytes.

Authors:  I C MacLennan; G Loewi
Journal:  Nature       Date:  1968-09-07       Impact factor: 49.962

4.  Block in insulin release from column-perifused pancreatic beta-cells induced by islet cell surface antibodies and complement.

Authors:  T Kanatsuna; A Lernmark; A H Rubenstein; D F Steiner
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

5.  Antibodies direct against the pancreatic islet cell plasma membrane. Detection and specificity.

Authors:  A Lernmark; T Kanatsuna; C Patzelt; K Diakoumis; R Carroll; A H Rubenstein; D F Steiner
Journal:  Diabetologia       Date:  1980-11       Impact factor: 10.122

6.  Islet-cell-surface antibodies in juvenile diabetes mellitus.

Authors:  A Lernmark; Z R Freedman; C Hofmann; A H Rubenstein; D F Steiner; R L Jackson; R J Winter; H S Traisman
Journal:  N Engl J Med       Date:  1978-08-24       Impact factor: 91.245

7.  Insulin-dependent diabetes: a disease of autoaggression.

Authors:  S W Huang; N K Maclaren
Journal:  Science       Date:  1976-04-02       Impact factor: 47.728

8.  Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus.

Authors:  M J Dobersen; J E Scharff; F Ginsberg-Fellner; A L Notkins
Journal:  N Engl J Med       Date:  1980-12-25       Impact factor: 91.245

9.  Increased killer cell activity in insulin dependent (type 1) diabetes mellitus.

Authors:  M Sensi; P Pozzilli; A N Gorsuch; G F Bottazzo; A G Cudworth
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

10.  Lymphocytes from diabetics suppress insulin release in vitro.

Authors:  C Boitard; M Debray-Sachs; A Pouplard; R Assan; J Hamburger
Journal:  Diabetologia       Date:  1981-07       Impact factor: 10.122

View more
  4 in total

Review 1.  Autoantibodies in insulin-dependent diabetes mellitus.

Authors:  E Bosi; E Bonifacio
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

2.  Immunological aspect of non-obese diabetic mice: immune islet cell-killing mechanism and cell-mediated immunity.

Authors:  T Maruyama; I Takei; M Taniyama; K Kataoka; S Matsuki
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

Review 3.  The role of immunotherapy in type I diabetes mellitus.

Authors:  M E Geffner; B M Lippe
Journal:  West J Med       Date:  1987-03

Review 4.  Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.

Authors:  Nataraju Angaswamy; Venkataswarup Tiriveedhi; Nayan J Sarma; Vijay Subramanian; Christina Klein; Jason Wellen; Surendra Shenoy; William C Chapman; T Mohanakumar
Journal:  Hum Immunol       Date:  2013-07-19       Impact factor: 2.850

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.